• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者同时患有眼肌型重症肌无力和多发性硬化症:病例报告。

Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report.

机构信息

Department of Neurology, Chosun University College of Medicine, Gwangju, South Korea.

Department of Neurology, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.

出版信息

Medicine (Baltimore). 2022 Feb 25;101(8):e28887. doi: 10.1097/MD.0000000000028887.

DOI:10.1097/MD.0000000000028887
PMID:35212290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8878705/
Abstract

RATIONALE

Patients with myasthenia gravis may also have comorbid autoimmune diseases. Since both myasthenia gravis and neuromyelitis optica spectrum disease are mediated by antibodies, they are likely to occur together. However, since multiple sclerosis is an autoimmune disease that is not mediated by a specific antibody, it has fewer immune mechanisms in common with myasthenia gravis than neuromyelitis optica spectrum disease. We encountered a case of newly developed multiple sclerosis in a patient with myasthenia gravis.

PATIENT CONCERNS

A 46-year-old man was diagnosed with ocular myasthenia gravis 6 years ago and had been taking pyridostigmine to control his symptoms.

DIAGNOSIS

The patient developed right optic neuritis, and multiple sclerosis was suspected based on the brain magnetic resonance imaging findings. However, the required diagnostic criteria were not met.

INTERVENTIONS

Disease-modifying therapy was not initiated, and clinical progression of the disease was monitored.

OUTCOMES

One year after the onset of optic neuritis, the patient developed myelitis and was diagnosed with multiple sclerosis, prompting treatment with disease-modifying therapy.

LESSONS

When optic neuritis occurs in patients with myasthenia gravis, careful evaluation is necessary while considering the possibility that it may be the first symptom of a demyelinating central nervous system disease. Therefore, it is important to conduct shorter-interval monitoring and symptom screening for patients with neurological autoimmune diseases, such as myasthenia gravis, even if multiple sclerosis is not initially suspected, to achieve early detection of multiple sclerosis.

摘要

背景

重症肌无力患者可能同时患有合并自身免疫性疾病。由于重症肌无力和视神经脊髓炎谱系疾病都是由抗体介导的,因此它们很可能同时发生。然而,多发性硬化症是一种自身免疫性疾病,不是由特定抗体介导的,因此与视神经脊髓炎谱系疾病相比,与重症肌无力的免疫机制共同点较少。我们遇到了一例重症肌无力患者新发多发性硬化症的病例。

病例描述

一名 46 岁男性 6 年前被诊断为眼肌型重症肌无力,一直服用吡啶斯的明来控制症状。

诊断

患者出现右眼视神经炎,根据脑部磁共振成像结果怀疑多发性硬化症,但未达到所需的诊断标准。

干预措施

未启动疾病修正治疗,仅对疾病进展进行了监测。

结果

视神经炎发病 1 年后,患者出现脊髓炎,被诊断为多发性硬化症,从而开始进行疾病修正治疗。

教训

当重症肌无力患者出现视神经炎时,需要仔细评估,同时要考虑到这可能是脱髓鞘中枢神经系统疾病的首发症状。因此,对于重症肌无力等神经自身免疫性疾病患者,即使最初不怀疑多发性硬化症,也需要进行更短间隔的监测和症状筛查,以实现多发性硬化症的早期发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7d/8878705/207176b71396/medi-101-e28887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7d/8878705/d2a500b32892/medi-101-e28887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7d/8878705/207176b71396/medi-101-e28887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7d/8878705/d2a500b32892/medi-101-e28887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7d/8878705/207176b71396/medi-101-e28887-g002.jpg

相似文献

1
Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report.患者同时患有眼肌型重症肌无力和多发性硬化症:病例报告。
Medicine (Baltimore). 2022 Feb 25;101(8):e28887. doi: 10.1097/MD.0000000000028887.
2
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
3
NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.重症肌无力但未行胸腺切除术患者的NMO-IgG阳性视神经脊髓炎
J Neurol Sci. 2008 Dec 15;275(1-2):148-50. doi: 10.1016/j.jns.2008.06.038. Epub 2008 Aug 13.
4
Neuromyelitis optica and myasthenia gravis in a young Nigerian girl.一名年轻尼日利亚女孩患视神经脊髓炎和重症肌无力。
BMJ Case Rep. 2015 Sep 3;2015:bcr2014207362. doi: 10.1136/bcr-2014-207362.
5
Occurrence of CNS demyelinating disease in patients with myasthenia gravis.重症肌无力患者中枢神经系统脱髓鞘疾病的发生情况。
Neurology. 2007 Apr 17;68(16):1326; author reply 1327.
6
Hypophonia as only presenting symptom in myasthenia gravis - a diagnostic dilemma in poor countries: a case report.以发声微弱为重症肌无力唯一表现症状——贫困国家中的诊断难题:一例病例报告
J Med Case Rep. 2019 Mar 2;13(1):48. doi: 10.1186/s13256-019-1970-6.
7
[Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].视神经脊髓炎谱系障碍、系统性红斑狼疮和重症肌无力合并所致横贯性脊髓炎综合征
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(7. Vyp. 2):97-106. doi: 10.17116/jnevro202012007297.
8
Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population.视神经脊髓炎合并重症肌无力:日本人群中的特征性表型
Eur J Neurol. 2006 Jun;13(6):655-8. doi: 10.1111/j.1468-1331.2006.01392.x.
9
Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.希卡姆格言:重症肌无力与格雷夫斯病同时出现。
BMJ Case Rep. 2017 Sep 7;2017:bcr-2017-220153. doi: 10.1136/bcr-2017-220153.
10
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.吸烟与眼肌型重症肌无力患者的日常生活活动
J Neuroophthalmol. 2016 Mar;36(1):37-40. doi: 10.1097/WNO.0000000000000306.

引用本文的文献

1
Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review.依奈西单抗治疗同时患有水通道蛋白4-IgG阳性视神经脊髓炎谱系障碍和重症肌无力的患者:病例报告及文献综述
Front Immunol. 2025 Jan 13;15:1528989. doi: 10.3389/fimmu.2024.1528989. eCollection 2024.
2
Relationship between medical history and multiple sclerosis: A-case-control study.病史与多发性硬化症的关系:病例对照研究。
Medicine (Baltimore). 2023 Jun 9;102(23):e33906. doi: 10.1097/MD.0000000000033906.